Transesophageal Echocardiography
The transesophageal echocardiographic examination has been previously described.7 Patients were asked to abstain from food and water 3-4 hours before the examination. The oropharynx was liberally sprayed with Lidocaine aerosol before introduction of the probe. The procedure of transesophageal echocardiography was performed after a mild intravenous sedation with midazolam (mean dose, 1.5 mg) and 0.2 mg glycopyrollate. Patients were placed in the left lateral decubitus position. The two methods of intubation of the esophagus include 1) digital, in which the examiner depresses the tongue with the digits of the fingers and introduces the probe asking the patient to assist by swallowing, and 2) nondigital, in which the probe is introduced in the patient's mouth, and then swallow-assisted examination is performed while gently pushing the probe. A complete examination that included obtaining the transgastric view from the fundus of the stomach was obtained in all patients. No procedure-related complications were noted in any of the 49 patients.
Blood Cultures
For each patient, blood cultures were obtained immediately before transesophageal echocardiography (time 0) and at 5, 10, and 20 minutes after esophageal intubation. Each culture was obtained by specially trained phlebotomists from a separate venipuncture site. Blood cultures were performed as described by Henry et al. 8 In brief, after preparation of the skin at the phlebotomy site with povidoneiodine, 30 ml venous blood was obtained with a single syringe and needle. A new needle was used to inoculate 10 ml blood into each of a 10-ml Isolator tube (E.I. DuPont de Nemours and Co., Inc., Dover, Del.), a Roche Septi-Chek bottle (Roche Diagnostic Systems, Inc., Nutley, N.J.) containing 70 ml growth medium with 0.05% sodium polyanetholesulfonate and an atmosphere of 5% C02, and a bottle containing 100 ml Tryptic soy broth (Difco, Detroit, Mich.) in an anaerobic atmosphere with 5% CO2 and 0.025% SPS. The Roche bottle was vented transiently, and the agar-slide chamber was attached upon receipt in the laboratory. The Tryptic soy broth bottle remained unvented. The Isolator tube was processed according to the manufacturer's directions, and the concentrate was inoculated onto 5% sheep blood agar, chocolate blood agar, inhibitory mold agar, Sabouraud agar, and brain-heart infusion agar.
Bottle cultures were incubated at 35°C in room air for 14 days and were examined macroscopically at least daily for 7 days and before being discarded. The Roche bottle was tipped at each examination to allow the blood-broth mixture to flow over the agar slide and to function as a subculture. The nonventedTryptic soy broth bottle was not subcultured unless there was macroscopic evidence of microbial growth. Routine Gram stains were not done of cultures without evidence of growth. Sheep blood agar and chocolate blood agar plates from the Isolator tube were incubated at 35°C in air with 5-10% CO2 for 3 full days and examined at least daily. The remaining media were incubated in room air at 30°C for 21 days and were examined primarily for growth of yeasts or fungi. Bacterial growth that was not on an inoculum streak was ignored. Similarly, single colonies of viridans group streptococci, coagulase-negative staphylococci, Bacillus spp., Propionibacterium spp., Corynebacterium spp., or Neisseria spp. (except N. meningitidis or N. gonorrhoeae) growing only on Isolator plates from a single culture were assumed to be contaminants and were not reported by the microbiology laboratory or included in the data for this study.
Bacterial growth was identified using a combination of Gram stain, rapid tests, conventional biochemical procedures, and gas-liquid chromatography, as appropriate. 9 
Data Analysis
Before patient enrollment, a study size of 45-50 patients was selected based on an estimated 80% probability of detecting a 15% or higher risk of bacteremia with type I (a) error of 0.05 or less. Confidence intervals were determined assuming the data followed a binomial distribution.
Results
Forty-nine patients (30 men and 19 women) with a median age of 71 years (range, 18-86 years) were studied.
The clinical indication for transesophageal echocardiography was assessment for the source of an embolus in 34 patients, valve dysfunction in seven patients, aortic pathology in two patients, dysrhythmia in five patients, and intracardiac shunt in one patient. Five patients had prosthetic valves. Eighteen patients were edentulous; 29 of the remaining 31 patients had no evident periodontal or gingival disease. The esophagus was intubated with the digital technique in 21 patients and with the nondigital technique in 28 patients. The mean number of intubation attempts was two (range, one to eight). The mean (+SD) transesophageal echocardiography procedure time was 19+12 minutes.
In two patients, only the first two blood cultures could be collected according to the protocol because of a subsequently difficult venous access. The four blood cultures obtained in these two patients were negative. Among the remaining 47 patients, two of 47 preechocardiographic cultures were positive, one with Clostridium pefringens and one with Flavobacterium species. Both patients were asymptomatic, all subsequent cultures were negative, and the isolates were clinically considered to be contaminants. Two of 141 subsequent cultures during or immediately after transesophageal echocardiography were positive with coagulase-negative staphylococci. These cultures were obtained from different patients at 5 and 15 minutes after the procedure was begun. In each patient, the staphylococcus was isolated from only one medium of the culture set and was considered to be a contaminant. 9 Thus, the frequency of any positive blood cultures in patients before transesophageal echocardiography was two of 49 (4%) compared with two of 141 (1.4%) during and after transesophageal echocardiography (p=NS, Sign test) reflecting the contamination rate. No clinically significant bacteremias during or after transesophageal echocardiography were detected (0 of 141 cultures: 95% CI, 0-2.6%; 0 of 47 patients: 95% CI, 0-7.5%). In no patients were cultures repeatedly positive for the same organism. At last follow-up, no patient had evidence of endocarditis or other significant infection.
Discussion
By prospectively evaluating the occurrence of bacteremia during transesophageal echocardiography in 49 patients, we found no procedure-related episodes of bacteremia due to oral bacteria susceptible to standard antimicrobial prophylaxis for endocarditis.
The blood culture method that was used has been extensively evaluated8 and is consistent with methods currently recommended for optimal recovery of bacteria.10-12 Coagulase-negative staphylococci are the most common contaminants using this system, and the finding of coagulase-negative staphylococci in two of 143 cultures is consistent with the historical frequency of contamination of approximately 1.5% in this culture system (Anhalt JP, unpublished data).
Gorge et al13 prospectively studied 24 patients with two blood cultures obtained simultaneously [6] [7] [8] [9] [10] [11] [12] minutes after beginning transesophageal echocardiography and found four patients (17%) with positive blood cultures. Although in all four patients, both blood cultures were positive for microorganisms, in only one patient was the same organism (coagulasenegative staphylococci) recovered from both cultures. In none of the four reported cases would all isolates have been expected to be susceptible in vitro to penicillin or ampicillin, which have been recommended for prophylaxis in this setting.1 '13 Other preliminary reports, which have included blood cultures either before transesophageal echocardiography or in other control populations, have also found a frequency of positivity and distribution of microorganisms reflecting the normal rate of contamination at those centers.14,15
Conclusions
In a prospective study of bacteremia associated with transesophageal echocardiography, the frequency of any positive blood cultures was no higher than the background contamination rate observed in the same patient population before the procedure. No clinically significant bacteremias due to oral microbes susceptible to standard endocarditis prophylaxis regimens were detected. Because of the small number of patients studied, our data suggest a 95% probability that the true rate is less than 7.5%. This frequency of bacteremia is similar to that reported from other centers13,14 and similar to or less than that reported for flexible bronchoscopy and gastrointestinal endoscopy.
At our institution, we include transesophageal echocardiography among the types of low risk procedure for which endocarditis prophylaxis is generally not recommended in accordance with current American Heart Association recommendations. 16 Patients with overt dental infection have higher risk of bacteremia and should receive treatment or prophylaxis. Likewise, in accordance with American Heart Association recommendations, some clinicians may elect to offer prophylaxis to patients at high risk of endocarditis undergoing low-risk procedures. Patients at high risk include those with prosthetic heart valves or a history of previous endocarditis.
